MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…

MedMen terminated its $682 million merger with PharmaCann on Tuesday, in a move one analyst called a "surprise." The merger's cancellation points to a challenging dealmaking environment in the cannabis industry as the sector has…